Doximity, Inc. Class A (DOCS)

Doximity's stock price has declined significantly over the past six months. Weak Q4 FY2026 guidance, attributed to delayed budget commitments from pharmaceutical companies, triggered a stock decline. An analyst downgrade by Evercore, citing execution challenges and slowed growth, further contributed to the stock hitting a new 52-week low. The company authorized a new share repurchase program. Insiders sold shares worth $0.2 million with no reported buying activity.

Demand for Doximity's products and services is influenced by the budget cycles of its pharmaceutical and healthcare system clients. Delays in budget commitments from major pharmaceutical companies negatively impacted Q4 FY2026 revenue guidance. The company reported its best January bookings growth since going public, suggesting a potential seasonal uptick in client spending at the beginning of the calendar year.

Doximity, Inc. is a digital platform for medical professionals in the United States, operating within the Healthcare sector and the Health Information Services industry. The company aims to enhance physician productivity and improve patient care by providing digital tools. Its platform offers tools for collaboration, medical news updates, career management, on-call scheduling, documentation streamlining, and virtual patient visits. Major products and services include Dialer and Dialer Video for telehealth, Secure Messaging and eFax for communication, Amion for on-call scheduling, Doximity GPT for AI assistance, Residency Navigator for medical students, Marketing Solutions for targeted content delivery, and Hiring Solutions for digital recruiting.

Doximity primarily operates in the United States, with its headquarters in San Francisco, California. Its platform serves over 80% of U.S. physicians across all 50 states. The acquisition of Canadian startup Pathway Medical in August 2025 suggests a potential expansion into the Canadian market.

Doximity has maintained a strong brand reputation in telehealth, with Doximity Dialer recognized as a leading platform. The company's ability to rapidly recover customer acquisition costs indicates a differentiated product offering. Concerns have been raised about pre-populated profiles. Recent reports indicate improving perception and adoption of their AI tools.

Doximity's stock ownership includes institutional investors holding a significant portion, insiders owning a smaller percentage, and public companies and individual investors. Major institutional owners include BlackRock, Inc., Vanguard Group Inc, Capital World Investors, William Blair Investment Management, Llc, Clearbridge Investments, LLC, State Street Corp, Geode Capital Management, Llc, Baillie Gifford & Co, Citadel Advisors Llc, and Invesco Ltd. Morgenthaler Venture Partners IX LP is a significant individual shareholder.